Facilities
/ Manufacturing Plant
- Home /
- BSF Technologies /
- Facilities
Facility
& Capacity
Our primary and secondary packaging operations are designed to support both high-volume commercial production and small, specialized batches— always with the same commitment to quality and flexibility.
Location
GETAFE
Spain
Annual capacity
Up to
600
MILLION
UNITS
PER YEAR
UNITS
PER YEAR
Out-licensing (vademécum)
- Ophthalmology
- Respiratory
Product | Therapeutic area | License | Format |
---|---|---|---|
Isotonic Saline Solution 0.9% | Eyes, nose and contact lenses | MD (IIb) | Since 0,4ml to 10 ml |
Buffered Saline Solution | Eyes, nose and contact lenses | MD (IIb) | 5 ml |
Moisturizing solution 0.10% + Hyaluronic Acid | Eyes, contact lenses | MD (IIb) | 0,4 ml |
Product | Therapeutic area | License | Format |
---|---|---|---|
Isotonic Saline Solution 0.9% | Nebulization / Inhalation | MD (IIa) | 5 ml |
Isotonic Saline Solution 0.9% + Hyaluronic Acid | Nebulization / Inhalation | MD (IIa) | 5 ml |
Hypertonic Saline Solution 1.5% | Nebulization / Inhalation | MD (IIa) | 5 ml |
Hypertonic Saline Solution 3% | Nebulization / Inhalation | MD (IIa) | 5 ml |
Hypertonic Saline Solution 3% + Hyaluronic Acid | Nebulization / Inhalation | MD (IIa) | 5 ml |
Hypertonic Saline Solution 5% | Nebulization / Inhalation | MD (IIa) | 5 ml |
Hypertonic Saline Solution 7% + Hyaluronic Acid | Nebulization / Inhalation | MD (IIa) | 5 ml |